Literature DB >> 34817725

Lower uric acid level may be associated with hemorrhagic transformation after intravenous thrombolysis.

Yuxuan Tian1, Qianqian Xie1, Jiulin You1, Shaonan Yang1, Hongqin Zhao1, Yuqiang Song2.   

Abstract

BACKGROUND: Previous studies have shown that uric acid (UA) is a powerful water-soluble antioxidant and free radical scavenger for humans. However, the relationship between serum uric acid (SUA) and hemorrhagic transformation (HT) is still controversial. To address this challenge, we aimed to explore the association between serum UA and HT in patients with acute ischemic stroke (AIS) after intravenous thrombolysis (IVT).
METHODS: A retrospective analysis was conducted in patients with anterior circulation AIS who underwent IVT at Affiliated Hospital of Qingdao University from 2016 to 2021. HT was evaluated by CT or MRI within 7 days after admission. Baseline demographic, clinical, and laboratory data were compared between the HT and non-HT groups, and between different types of HT groups which were documented according to the European Cooperative Acute Stroke Study III Classification (ECASS III).
RESULTS: A total of 727 AIS patients were enrolled, including 112 patients who experienced HT (HT group) and 615 patients who did not experience HT (non-HT group). Patients with HT had significantly lower UA levels compared to those without HT (253.65 ± 97.75 vs 315.97 ± 96.42, p < 0.001); however, there was no significant difference for UA levels in different types of HT (p = 0.907). After adjusting confounders, patients in the fourth UA quartile showed a significant decrease in HT compared with those in the first quartile (OR 0.266, 95% CI 0.107-0.661, p = 0.006). The best cutoff value was identified as 218.5 μmol/L after analysis.
CONCLUSIONS: These findings suggest that low levels of UA may be associated with HT after IVT.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Acute cerebral stroke; Hemorrhagic transformation; Intravenous thrombolysis; Uric acid

Mesh:

Substances:

Year:  2021        PMID: 34817725     DOI: 10.1007/s10072-021-05760-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  25 in total

Review 1.  Simultaneous acute cardio-cerebral infarction: is there a consensus for management?

Authors:  Oluwaseun A Akinseye; Muhammad Shahreyar; Mark R Heckle; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

2.  Predictors of hemorrhagic transformation after acute ischemic stroke based on the experts' opinion.

Authors:  João Brainer Clares de Andrade; Jay Preston Mohr; Fabricio Oliveira Lima; Levi Coelho Maia Barros; Camila Rodrigues Nepomuceno; Leonardo Barreira Portela; Gisele Sampaio Silva
Journal:  Arq Neuropsiquiatr       Date:  2020-05-11       Impact factor: 1.420

3.  Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.

Authors:  Sergio Amaro; Víctor Obach; Alvaro Cervera; Xabier Urra; Manuel Gómez-Choco; Anna M Planas; Angel Chamorro
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 4.  Factors influencing haemorrhagic transformation in ischaemic stroke.

Authors:  José Álvarez-Sabín; Olga Maisterra; Estevo Santamarina; Carlos S Kase
Journal:  Lancet Neurol       Date:  2013-05-31       Impact factor: 44.182

5.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

6.  Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.

Authors:  Angel Chamorro; Sergio Amaro; Mar Castellanos; Tomás Segura; Juan Arenillas; Joan Martí-Fábregas; Jaime Gállego; Jurek Krupinski; Meritxell Gomis; David Cánovas; Xavier Carné; Ramón Deulofeu; Luis San Román; Laura Oleaga; Ferran Torres; Anna M Planas
Journal:  Lancet Neurol       Date:  2014-04-02       Impact factor: 44.182

7.  Blood-Brain-Barrier Leakage and Hemorrhagic Transformation: the Reperfusion Injury in Ischemic StroKe (RISK) study.

Authors:  Francesco Arba; Benedetta Piccardi; Vanessa Palumbo; Silvia Biagini; Francesco Galmozzi; Veronica Iovene; Alessio Giannini; Giuseppe Dario Testa; Alessandro Sodero; Mascia Nesi; Davide Gadda; Marco Moretti; Mari Lamassaa; Francesca Pescini; Anna Poggesi; Cristina Sarti; Stefania Nannoni; Giovanni Pracucci; Nicola Limbucci; Sergio Nappini; Leonardo Renieri; Stefano Grifoni; Enrico Fainardi; Domenico Inzitari; Patrizia Nencini
Journal:  Eur J Neurol       Date:  2021-06-18       Impact factor: 6.089

8.  Lower uric acid level may be associated with hemorrhagic transformation but not functional outcomes in patients with anterior circulation acute ischemic stroke undergoing endovascular thrombectomy.

Authors:  Zhongyun Chen; Hongbo Chen; Yingbo Zhang; Yanbo He; Yingying Su
Journal:  Metab Brain Dis       Date:  2020-07-08       Impact factor: 3.584

Review 9.  Uric acid therapy for vasculoprotection in acute ischemic stroke.

Authors:  Sergi Amaro; Francesc Jiménez-Altayó; Ángel Chamorro
Journal:  Brain Circ       Date:  2019-06-27

10.  Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke.

Authors:  Zhiliang Guo; Shuhong Yu; Lulu Xiao; Xin Chen; Ruidong Ye; Ping Zheng; Qiliang Dai; Wen Sun; Changsheng Zhou; Shuiping Wang; Wusheng Zhu; Xinfeng Liu
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 8.322

View more
  2 in total

1.  A novel nomogram to predict hemorrhagic transformation in ischemic stroke patients after intravenous thrombolysis.

Authors:  Miaomiao Yang; Wei Zhong; Wenhui Zou; Jingzi Peng; Xiangqi Tang
Journal:  Front Neurol       Date:  2022-09-08       Impact factor: 4.086

2.  Uric Acid and Clinical Outcomes in Young Patients with Ischemic Stroke.

Authors:  Yanfang Liu; Xinmin Liu; Jiaokun Jia; Jiahuan Guo; Guangshuo Li; Xingquan Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-29       Impact factor: 2.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.